As is often the case with cancer treatments, many patients are able to benefit from therapy for a time. Tumor activity ...

Moving gemcitabine/nab-paclitaxel to every-other-week dosing decreases infusion visits and may lessen cumulative toxicity, ...

A recent study published in the journal Frontiers in Endocrinology investigated the role of the short-chain dehydrogenase/reductase 42E member 1 (SDR42E1) enzyme in regulating sterol metabolism and ...

Novel use of clinical pathways to improve clinical trial accrual. Exploring the use of health information technology in the awareness of genetic testing among individuals with a family history of ...

New research shows that physical pressure from brain tumors or injuries triggers a "self-destruction" program in neurons, leading to irreversible brain damage.

Despite the significance of immune checkpoint inhibitors (ICIs) in solid tumor treatment, identifying ICI-sensitive populations remains a challenge. Mutations in DNA damage response (DDR) pathway ...

We urgently need research to understand the factors driving ethnic inequalities in prostate cancer outcomes, say Habib Naqvi ...

Premenopausal women would benefit from a significantly more accurate diagnostic pathway for ovarian cancer, as a new study ...

Cancer survival hits 70% as early screening and immunotherapy advance—yet survivorship needs and Indigenous disparities demand urgent action.

Somerset NHS launches England’s first breast cancer self-referral pathway via NHS 111, enabling faster specialist access and earlier diagnosis for patients.